UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 14, 2022

Accession Number:	0001193125-22-072315
Submission Type:	POS AM
CIK: 0001816736 Company Name: Gemini Therapeutics, Inc. /DE File Number: 333-253175